$0.11
(Market cap
--
Revenue (TTM)
--
P/E Ratio
--
P/B Ratio
--
Div. Yield
--
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
--
-
ROE
--
-
ROCE
--
-
Industry P/E
--
-
EV/EBITDA
--
-
Debt to Equity
--
-
Book Value
--
-
EPS
--
-
Face value
--
-
Shares outstanding
--
Years Aggregate
CFO
$--
EBITDA
$--
Net Profit
$--
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
NVIVQ (NVIVQ)
| -49.3 | -- | -- | -72.6 | -71.8 | -75.3 | -70.4 |
|
BSE Sensex*
| -9.2 | -1.4 | 2.8 | -3.7 | 5.7 | 6.2 | 10.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout NVIVQ (NVIVQ)
InVivo Therapeutics Holdings Corp. operates as a research and clinical-stage biomaterials and biotechnology company in the United States. The company engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal... cord injuries (SCI). It is developing a Neuro-Spinal Scaffold implant comprise of biocompatible and bioresorbable polymers, which includes Poly lactic-co-glycolic acid, a polymer which is widely used in resorbable sutures and provides the biocompatible support for Neuro-Spinal Scaffold implant; and Poly-L-Lysine, a positively charged polymer used to coat surfaces to promote cellular attachment. The company was incorporated in 2003 and is headquartered in Cambridge, Massachusetts. Read more
-
President, CEO, Chief Medical Officer & Director
Dr. Richard M. Toselli M.D.
-
CFO & Treasurer
Mr. Richard C. Christopher
-
Headquarters
Cambridge, MA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for NVIVQ (NVIVQ)
What is the current share price of NVIVQ (NVIVQ) Today?
The share price of NVIVQ (NVIVQ) is $0.37 (NASDAQ) as of 26-Jul-2024 09:30 EDT. NVIVQ (NVIVQ) has given a return of -71.8% in the last 3 years.
What is the current PB & PE ratio of NVIVQ (NVIVQ)?
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2022 |
-0.57 |
0.38 |
2021 |
-- |
-- |
2020 |
-- |
-- |
2019 |
-- |
-- |
2022 |
-0.57 |
0.38 |
What is the 52 Week High and Low of NVIVQ (NVIVQ)?
The 52-week high and low of NVIVQ (NVIVQ) are Rs -- and Rs -- as of 31-Aug-2026.
What is the market cap of NVIVQ (NVIVQ)?
NVIVQ (NVIVQ) has a market capitalisation of -- as on 26-Jul-2024. As per SEBI classification, it is a company.
Should I invest in NVIVQ (NVIVQ)?
Before investing in NVIVQ (NVIVQ), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.